Dilution of share value from the exercise of stock acquisition rights
First written in FY2022. 8 of 9 entries say "Materialised", first in FY2023-Q1. Latest entry: FY2026-H1.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026-H1MaterialisedAnnual report
「During the six months ended 30 June, we disposed of 49,028 treasury shares through the exercise of stock options and other transactions.」
During the first half of fiscal 2026, 49,028 treasury shares were disposed of through stock-option exercises and other transactions, continuing the transfer of shares upon exercise of potential shares. - FY2025MaterialisedAnnual report
「The decrease of 42,138 common treasury shares consisted of a decrease of 3,538 shares from the disposal of treasury shares as restricted stock compensation and 38,600 shares from the exercise of stock options.」
In fiscal 2025, 38,600 treasury shares were reduced through stock-option exercises, continuing the transfer of shares arising from dilution. - FY2024MaterialisedAnnual report
「As of 31 December 2024, the number of potential shares under stock acquisition rights was 419,520, equivalent to 2.0% of total issued shares.」
In 2024, 16,240 shares were issued through exercise of stock acquisition rights. At year-end, potential shares were 419,520, or 2.0% of total issued shares. - FY2024-Q1MaterialisedAnnual report
「1 January 2024–31 March 2024 16,240 21,343,600 5,075 1,649,759 5,075 1,629,759. The increase resulted from the exercise of stock acquisition rights.」
During the first quarter of 2024, 16,240 shares were added through exercise of stock acquisition rights, bringing total issued shares to 21,343,600. Dilution continued to be reflected in actual share issuance. - FY2023MaterialisedAnnual report
「As of 31 December 2023, the number of potential shares under stock acquisition rights was 440,560, equivalent to 2.1% of total issued shares.」
During 2023, 48,330 common shares were added through exercise of stock acquisition rights. At year-end, potential shares were 440,560, or 2.1% of total issued shares. - FY2023-Q3MaterialisedAnnual report
「1 July 2023–30 September 2023 520 5,323,010 650 1,633,646 650 1,613,646. The increase resulted from the exercise of stock acquisition rights.」
During the third quarter, 520 shares were added through exercise of stock acquisition rights. A further 4,000 shares were added between 1 October and 31 October, indicating continued dilution. - FY2023-Q2MaterialisedAnnual report
「1 April 2023–30 June 2023 17,980 5,322,490 22,475 1,632,996 22,475 1,612,996. The increase resulted from the exercise of stock acquisition rights.」
During the second quarter, 17,980 shares were added through exercise of stock acquisition rights, bringing total issued shares to 5,322,490. A further increase of 520 shares was disclosed for July before filing. - FY2023-Q1MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights. Between 1 April and 30 April 2023, total issued shares increased by 12,020 through the exercise of stock acquisition rights.」
During the first quarter, 6,510 shares were added through the exercise of stock acquisition rights, and a further increase of 12,020 shares was disclosed for April before filing. Dilution from exercise of potential shares was reflected in actual issuance. - FY2022First statedAnnual report
「As of 31 December 2022, the number of potential shares attributable to stock acquisition rights was 147,580, equivalent to 2.9% of the total number of issued shares.」
The Company indicates that the exercise of stock acquisition rights granted to motivate directors and employees could dilute existing shareholders’ share value and voting percentages.